Vaccinex, Inc.
VCNX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001205922
No open-market purchases or sales by Vaccinex, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Vaccinex, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 28 | 1 | 23 | −4 |
| Shares | 1.62M | 100 | 1.55M | −67.9K (−4.2%) |
| Value | $4.54M | $0 | $3.36M | −$1.18M (−26.0%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (2)
Institutions that held Vaccinex, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Natixis | 31,895 | $69.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 2,524 | $5.00K | 0.00% |
Sold out (6)
Institutions that held Vaccinex, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Virtu Financial LLC | 38,026 | $106.0K |
| Goldman Sachs Group Inc | 21,488 | $60.0K |
| Institute for Wealth Management, LLC. | 20,000 | $56.0K |
| Citadel Advisors LLC | 15,496 | $43.0K |
| Cutler Group LP | 1,300 | $3.00K |
| Panagora Asset Management Inc | 443 | $1.00K |
Not filed for Q3 2021 yet (1)
Institutions that held Vaccinex, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Hoover Financial Advisors, Inc. | 100 | $0 |